K. Atutxa

Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project

A. Bárez, P. Alfonso, M. Pocovi, 2009, Haematologica.

Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project.

L. Villalón, A. Acedo, A. Bárez, 2018, Blood cells, molecules & diseases.

Numb chin syndrome in 4 patients with hematologic malignancies.

A. Capelastegui, J. Ojanguren, C. García-Moncó, 1999, Haematologica.

Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-a therapy

A. Capelastegui, J. Ojanguren, C. García-Moncó, 1999 .

Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project.

L. Villalón, A. Acedo, A. Bárez, 2018, Blood cells, molecules & diseases.

Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project

A. Bárez, P. Alfonso, M. Pocovi, 2009, Haematologica.

Substrate Reduction Therapy With Miglustat In Type 1 Gaucher Disease In Spain. Nine Years Outcomes Update On ZAGAL Study

L. Villalón, A. Bárez, E. Luño, 2013 .